292 related articles for article (PubMed ID: 26777402)
1. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Alterations to Bile Ducts and Laboratory Values During the First 3 Months After Irreversible Electroporation of Malignant Hepatic Tumors.
Bäumler W; Sebald M; Einspieler I; Schicho A; Schaible J; Wiggermann P; Dollinger M; Stroszczynski C; Beyer LP
Cancer Manag Res; 2020; 12():8425-8433. PubMed ID: 32982436
[TBL] [Abstract][Full Text] [Related]
5. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study.
Niessen C; Igl J; Pregler B; Beyer L; Noeva E; Dollinger M; Schreyer AG; Jung EM; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2015 May; 26(5):694-702. PubMed ID: 25812712
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
[TBL] [Abstract][Full Text] [Related]
8. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
[TBL] [Abstract][Full Text] [Related]
9. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
[TBL] [Abstract][Full Text] [Related]
10. Biliary complications and efficacy after ablation of peribiliary tumors using irreversible electroporation (IRE) or radiofrequency ablation (RFA).
Thamtorawat S; Patanawanitkul R; Rojwatcharapibarn S; Chaiyasoot W; Tongdee T; Yodying J; Sorotpinya S
Int J Hyperthermia; 2022; 39(1):751-757. PubMed ID: 35649727
[TBL] [Abstract][Full Text] [Related]
11. Assessment of chronological effects of irreversible electroporation on hilar bile ducts in a porcine model.
Choi JW; Lu DS; Osuagwu F; Raman S; Lassman C
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):224-30. PubMed ID: 24196262
[TBL] [Abstract][Full Text] [Related]
12. Acute and subacute effects of irreversible electroporation on normal common bile ducts in a rabbit model.
Li Q; Ren F; Zhang Y; Chang P; Wang Y; Ma T; Hu L; Wu R; Wang B; Lv Y
J Hepatobiliary Pancreat Sci; 2020 Oct; 27(10):776-784. PubMed ID: 32696618
[TBL] [Abstract][Full Text] [Related]
13. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
14. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR
Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.
Sugimoto K; Moriyasu F; Kobayashi Y; Saito K; Takeuchi H; Ogawa S; Ando M; Sano T; Mori T; Furuichi Y; Nakamura I
Jpn J Radiol; 2015 Jul; 33(7):424-32. PubMed ID: 26032929
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study.
Barabasch A; Distelmaier M; Heil P; Krämer NA; Kuhl CK; Bruners P
Invest Radiol; 2017 Jan; 52(1):23-29. PubMed ID: 27379698
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.
Granata V; Fusco R; Catalano O; Piccirillo M; De Bellis M; Izzo F; Petrillo A
AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma.
Hsiao CY; Yang PC; Li X; Huang KW
Sci Rep; 2020 Jul; 10(1):10883. PubMed ID: 32616770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
